Physician

Achankeng Afiadata, M.D.

According to 2025 Medicare claims, Achankeng Afiadata, M.D. (NPI: 1851786321) practices urology in the Rocky Mount, NC market, with the plurality of this provider's patient population coming from Nash, NC. This provider's primary affiliated billing organization is UNC PHYSICIANS NETWORK LLC (NPI: 1558786830; TIN: 271081647) and primary practice location at 27804-2417. Afiadata is affiliated with the CHESS Genesis, LLC (ACO ID: D0237), participating under the REACH model.

Afiadata's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 645 traditional Medicare patients, billed 3,739 HCPCS/CPT codes, and received $176,495 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,516 prescription claims across 755 beneficiaries totaling $242,698 in drug costs, led by Myrbetriq (Mirabegron). 2023 DME data shows 12 claims. Open Payments data shows 8 records totaling $330. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,200 to $242,698. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	278	1,562	$65,206
2021	724	3,666	$193,302
2022	760	5,402	$184,290
2023	689	5,401	$171,365
2024	645	3,739	$176,495

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	39	68	$1,200
2016	46	69	$1,692
2017	75	122	$1,256
2018	96	149	$2,124
2019	96	154	$3,197
2020	189	434	$24,227
2021	518	1,647	$114,138
2022	661	2,907	$250,924
2023	739	3,362	$271,776
2024	755	3,516	$242,698

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	14	$3,663
2023	N/R	12	$3,487
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	368	539	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	357	453	$54
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	421	673	$11
51798	Ultrasound measurement of bladder capacity after voiding	157	201	$7
81001	Manual urinalysis test with examination using microscope, automated	546	984	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	209	8,660	$130,567
Tamsulosin Hcl	Tamsulosin Hcl	1,265	95,922	$17,996
Gemtesa	Vibegron	25	1,050	$16,411
Elmiron	Pentosan Polysulfate Sodium	12	360	$11,638
Estradiol	Estradiol	135	7,125	$9,233

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$330	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Achankeng Afiadata, M.D.?

Tedicare shows public-source Medicare data for Achankeng Afiadata, M.D. (NPI 1851786321), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Achankeng Afiadata, M.D. have ACO affiliation data?

Achankeng Afiadata, M.D. is shown with ACO affiliation data for CHESS Genesis, LLC (REACH, ACO ID D0237).

What billing organization is linked to Achankeng Afiadata, M.D.?

Achankeng Afiadata, M.D. is linked to UNC PHYSICIANS NETWORK LLC (billing NPI 1558786830) in the available physician profile data.

Does Achankeng Afiadata, M.D. have Open Payments data?

Achankeng Afiadata, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.